We take a partner-friendly approach to licensing. As the owners rather than the licensees of our technology, we have significant leeway in our ability to structure deals to be mutually beneficial. In particular, we avoid front-loaded, claw-back laden deals, and instead favour close working relationships, mutual alignment for downstream benefit, success-based milestones, and minimal performance clause requirements for our collaborations.
How much access do I have to the research?
Since we work closely with our partners, our partners get to see the research results in real time, as they unfold, and also have the opportunity to play a significant role in forming the directions of future inquiry. We understand and apply trade secret and confidentiality constraints to all our work, and require our partners to do the same.
Who owns the intellectual property?
We own all of our intellectual property, which is then licensed to our partners on an exclusive or non-exclusive basis, as appropriate.
Do you publish your results? What about trade secrets?
We understand that often it is in the best interests of commercial development to not publish results, or at least to delay their publication. On the other hand, sometimes it can be very valuable for a company’s marketing efforts to announce seminal discovery successes with great fanfare. We retain all of our work either as trade secrets or in patents, unless a mindful, mutual decision is made by our partners and ourselves to publish.